Deschloroketamine: Difference between revisions
>White m Text replacement - "{{Main|NMDA receptor antagonist}}" to "{{Further|NMDA receptor antagonist}}" |
>Cannabis Entity Grammatics |
||
Line 37: | Line 37: | ||
*'''[[Effect::Perception of decreased weight]]''' | *'''[[Effect::Perception of decreased weight]]''' | ||
*'''[[Effect::Physical autonomy]]''' - This is reported to be especially present at low doses and to be decreasing as the dose increases.{{citation needed}} | *'''[[Effect::Physical autonomy]]''' - This is reported to be especially present at low doses and to be decreasing as the dose increases.{{citation needed}} | ||
*'''[[Effect::Physical euphoria]]''' - This is reported be present even at low doses.{{citation needed}} | *'''[[Effect::Physical euphoria]]''' - This is reported to be present even at low doses.{{citation needed}} | ||
*'''[[Effect::Spatial disorientation]]''' | *'''[[Effect::Spatial disorientation]]''' | ||
*'''[[Effect::Spontaneous tactile sensations]]''' | *'''[[Effect::Spontaneous tactile sensations]]''' |